Chronic hyperglycemia desensitizes
H
yperglycemia impairs ␤-cell function in type 2 diabetic patients as evidenced by improved function after blood glucose normalization (1) (2) (3) . The mechanisms behind this effect are largely unclarified regarding the signal-secretion mechanisms that are altered. Calcium signaling is a potential target for desensitization because key elements in glucose recognition as a secretagogue are an increase in the intracellular Ca 2+ concentration ([Ca 2+ ] i ) (4) and oscillations of [Ca 2+ ] i (5) (6) (7) . Decreased glucose-induced insulin secretion associates with defects in glucose-stimulated [Ca 2+ ] i (8) (9) (10) , and toxic influences can profoundly affect oscillatory activity (11) . Also, studies in rodents indicate influences of hyperglycemia on [Ca 2+ ] i (10, (12) (13) (14) . However, it is not known whether prolonged glucose elevation exerts effects on [Ca 2+ ] i fluxes in human pancreatic islets and, if so, whether the effects are similar to those in rodent islets.
Both direct and indirect actions of hyperglycemia can be construed to cause altered ␤-cell function (15) (16) (17) (18) . Using animal models of diabetes, we (15, 19) and others (20) have demonstrated that overstimulation exerts a profound desensitizing influence on insulin responses to glucose. These studies used diazoxide as a probe for avoiding overstimulation. Diazoxide is known to block insulin secretion by opening ATPdependent K + channels in cell membranes of ␤-cells, thereby hyperpolarizing the cells and offsetting opposite effects by glucose (21) . In previous studies, we demonstrated that desensitization by overstimulation involves Ca 2+ inflow (15) . However, the effects of overstimulation on Ca 2+ fluxes as tested by diazoxide have been insufficiently clarified in animal studies and have not been investigated at all in human ␤-cells.
Against this background, we aimed to test the influence of 48 h of elevated glucose levels in human pancreatic islets in vitro on subsequent insulin and [Ca 2+ ] i responses to glucose. The specificity of such effects was tested by comparison with responses to arginine, which is a nonnutrient secretagogue. On finding that long-term elevated glucose profoundly affected [Ca 2+ ] i parameters, we tested the extent to which relief of overstimulation by diazoxide could normalize glucose-induced insulin release and [Ca 2+ ] i parameters.
RESEARCH DESIGN AND METHODS
Materials. Bovine serum albumin (BSA) (fraction V) and forskolin were purchased from Sigma (St. Louis, MO), diazoxide (Hyperstat) was purchased from ScheringPlough Labo (Heist-op-den-Berg, Belgium), and fura-2/acetoxymethyl ester (AM) was purchased from Molecular Probes Europe (Leiden, Holland). D-[U-A. BJÖRKLUND, A. LANSNER, AND V.E. GRILL cells and 13 ± 2% glucagon + cells. After isolation, islets were cultured in Ham's F10 medium containing 6.1 mmol/l glucose and were supplemented with 0.5% BSA, 0.08 mg/ml penicillin, and 0.1 mg/ml streptomycin. The culture period in Brussels varied between 2 and 32 days (11 ± 2 days) before the islets were sent by air to Uppsala, Sweden, in the same medium as described above supplemented with 2% newborn calf serum and 10 mmol/l HEPES (24) . There the islets were cultured in RPMI-1640 medium containing 5.5 mmol/l glucose, 2 mmol/l glutamine, 10% fetal calf serum, 100 U/ml benzylpenicillin, and 0.1 mg/ml streptomycin for 2-5 days before being transferred to our laboratory in Stockholm (transfer time ~1 h).
After arrival at our laboratory, the islets were transferred to new RPMI-1640 medium (with the same additions as above) and were cultured for 2 days before experiments. The time that elapsed from islet isolation in Brussels to the start of the actual experiment was 20 ± 2 days (10-35 days). Islet culture. Islets were cultured in RPMI medium with 27 or 5.5 mmol/l glucose with or without diazoxide for 48 h while free-floating at 37°C with an atmosphere of 5% CO 2 95% air. The concentration of diazoxide when present was 325 µmol/l. Samples of the culture media were secured for insulin assay. Measurements of insulin release. After culture, islets were washed and transferred to 5 ml Krebs-Ringer bicarbonate buffer (KRBB) (25) containing 10 mmol/l HEPES, 0.2% BSA, and 3.3 mmol/l glucose. Islets were preincubated in this medium for 30 min at 37°C. Islets were then transferred to tubes containing 300 µl KRBB with 3.3 and 27 mmol/l glucose or, in some experiments, 3.3 mmol/l glucose and 10 mmol/l arginine. A total of 3 to 4 tubes with 3-5 islets each were run for each experimental condition. The final postculture incubations were carried out for 60 min at 37°C in a shaking water bath. At the end of the incubations, aliquots of the incubation medium were secured for insulin assay. At the same time, islets were retrieved and sonicated for 10-15 s. Sonication was followed by extraction of insulin overnight at 4°C in 200 µl acid ethanol (70% vol/vol). Islet glucose oxidation and glucose utilization. Glucose metabolism was measured after 30 min of preincubation in KRBB containing 3.3 mmol/l glucose. The parameters of glucose oxidation and utilization were determined by simultaneously measuring the formation of 14 (27) from the same batch of islets as described previously in detail (28) . Measurements of [Ca 2+ ] i . After culture, the islets were loaded in 2 ml KRBB with 3.3 mmol/l glucose and 2 µmol/l fura-2/AM for 40 min at 37°C under gentle agitation. Single islets were transferred to a small open perifusion chamber (volume 150 µl) with a coverslip bottom. Islets were gently fixed under a grid made of titan. The medium flow rate was 150 µl/min and was controlled by a peristaltic pump. The dead space of the perifusion system corresponded with a lag period of ~40 s. Fura-2 fluorescence was measured at 37°C with a SPEX Fluorolog-2 system coupled with an inverted epifluorescence microscope (Zeiss Axiovert 35M) equipped with a 40 ϫ 0.75 NA Plan-Neofluar objective. The measuring diaphragm was closed enough to exclude the brighter peripheral zone of the islet, thus minimizing the contribution of non-␤-cell fluorescence. Fura-2 was alternatingly excited at 340 and 380 nm by a beam chopper, and emitted light was collected at 515 nm by a photoncounting photometer. A 340/380-nm ratio was obtained at 1 Hz. Data were stored in the system computer. The apparent concentration of cytoplasmic Ca 2+ was calculated using the measured 340/380-nm ratios and calibrations by the equation described by Grynkiewicz et al. (29) with a dissociation constant (K d ) of 224 nmol/l. Linear correction was performed for each experiment to correct for trends at baseline before and after the stimulation period.
Insulin assay. Insulin was measured by radioimmunoassay using charcoal separation (30) . Human insulin was used as a standard. The insulin antibodies used had been raised in our laboratory against porcine insulin. 2+ ] i . Fourier analysis is a mathematical technique for assessing the contribution of oscillations of any periodicity to the total oscillatory activity in a data set. With this analysis, any oscillatory phenomenon can be described in terms of its component sinusoidal forms. Fourier analyses were pooled for islets cultured with 5.5 or 27 mmol/l glucose in the absence or presence of diazoxide, and the means ± SE of the spectral densities were obtained at each frequency. The period analyzed was between 300 and 1,300 s (i.e., the stable stimulated period of [Ca 2+ ] i measurements). The time series results for individual data sets were smoothed using a three-point moving average to reduce rapid fluctuations in the data because of assay or experimental noise. Time series analysis was performed using spectral analysis with STATISTICA software (StatSoft). Any linear time trends and low-frequency oscillations in [Ca 2+ ] i were eliminated using regression analysis (detrending) to filter out peaks with periods >20 min. Spectral analysis results were presented as a histogram of spectral density showing the total amplitude of oscillations and as relative spectral density graphs (expressed as the percentage of total density) showing the frequency distribution of oscillations. Expression of results. Data are means ± SE. In the case of islet insulin contents, results were adjusted for insulin released into postculture media. For significance testing with multiple comparisons, the one-way repeated-measures analysis of variance (ANOVA) was carried out. When the normality test failed, ANOVA on ranks was performed. Differences between two groups were evaluated using Student's t test. A P value < 0.05 was considered significant.
Analysis of oscillations in [Ca
The variability of basal and stimulated [Ca 2+ ] i levels was greater within versus between preparations. As an example, for basal [Ca 2+ ] i from 27-mmol/l glucose cultured islets, the coefficient of variation (CV) was 17.4% for islets from a single preparation, whereas the interpreparational CV was 14.5%. Therefore, each islet studied was entered as one observation.
RESULTS
Prolonged ␤-cell stimulation by 27 mmol/l glucose specifically desensitizes glucose-induced insulin release. Culture for 48 h with 27 vs. 5.5 mmol/l glucose increased the amount of insulin accumulated in culture media by fivefold. Reciprocally, islet insulin contents were decreased by 75%. After culture, islets cultured with 27 mmol/l glucose were almost totally unresponsive to postculture stimulation with glucose, whereas islets cultured with 5.5 mmol/l glucose responded with a 6.8-fold increase in secretion (Table 1) .
Fractional release (in percentage of insulin content) during final incubations with 3.3 mmol/l glucose was enhanced 8.6-fold in islets cultured in 27 mmol/l glucose vs. those cultured in 5.5 mmol/l glucose. However, during final incubations with 27 mmol/l glucose, fractional release failed to increase in islets, whereas a 5.5-fold increase was elicited in islets cultured with 5.5 mmol/l glucose. Diazoxide protects against desensitization of glucoseinduced insulin secretion after high-glucose culture.
Diazoxide was added to culture media to probe for the effects of overstimulation behind the desensitization to glucose. Coculture with diazoxide significantly reduced insulin accumulation in culture media after culture with both 5.5 and 27 mmol/l glucose (Table 1) . However, in absolute terms, the accumulation was much more inhibited with 27 mmol/l glucose. Coculture with diazoxide and 5.5 mmol/l glucose did not affect islet insulin content, whereas coculture with diazoxide and 27 mmol/l glucose increased islet insulin content 3.6-fold (Table 1) . Coculture with diazoxide and 27 mmol/l glucose restored a marked insulin response to renewed stimulation with glucose during postculture incubations (Table 1 ). In addition, previous diazoxide significantly increased the insulin release during basal conditions (i.e., in the presence of 3.3 mmol/l glucose). These effects could not be explained by an effect of diazoxide per se. Hence, after coculture with diazoxide and 5.5 mmol/l glucose, a significant decrease was evident in glucose-induced insulin secretion (Table 1) .
Fractional release after coculture with diazoxide and 27 mmol/l glucose was decreased in final incubations with 3.3 mmol/l glucose compared with islets cultured in 27 mmol/l glucose only (from 11 ± 1.3 to 5.8 ± 0.6%), although fractional release was increased relative to islets cultured with 5.5 mmol/l glucose (1.7 ± 0.6%). Fractional release in final incubations with 27 mmol/l glucose increased to 10 ± 0.8% after culture with diazoxide and 27 mmol/l glucose (i.e., to approximately the same levels seen after culture with 27 mmol/l glucose alone [12 ± 1.3%]). High-glucose culture or diazoxide does not desensitize glucose-induced arginine release. The desensitization to glucose strikingly contrasted with arginineinduced insulin responses. Islets cultured with high glucose thus displayed a definite response to this amino acid, whereas a response was lacking in low-glucose cultured islets (Table 2) . Furthermore, arginine-induced insulin secretion was not significantly affected by previous diazoxide (Table 2) . ] i recorded immediately before stimulation were markedly increased (by 61%) by culture with 27 vs. 5.5 mmol/l glucose (Table 3) .
Previous diazoxide counteracts high-glucose culture effects on basal [Ca

2+
] i . Coculture with diazoxide in the presence of 27 mmol/l glucose significantly lowered the elevated Data are means ± SE or n for 10 (27 mmol/l glucose) or 7 (5.5 mmol/l glucose) experiments. After loading with 2 µmol/l fura-2/AM for 40 min, islets were perifused for 20-30 min with a medium containing 3.3 mmol/l glucose. Thereafter, the concentration of glucose was increased to 27 mmol/l. Basal [Ca 2+ ] i was calculated at 3.3 mmol/l glucose before switching to 27 mmol/l glucose. Initial decrease was defined as a decrease >2 nmol/l. Increase of 5 nmol/l Ca 2+ , incremental Ca 2+ at first peak, and delay to first peak of Ca 2+ were calculated after switching to 27 mmol/l. Incremental mean Ca 2+ was calculated by integrating all [Ca 2+ ] i values between 300 and 1,300 s of stimulation with 27 mmol/l glucose. Off-response was defined as an increase >10 nmol/l after changing the medium back to 3.3 mmol/l glucose from 27 mmol/l glucose. *P < 0.01 vs. 5.5-mmol/l glucose cultured islets; †P < 0.03 vs. no diazoxide.
A. BJÖRKLUND, A. LANSNER, AND V.E. GRILL [Ca 2+ ] i caused by high-glucose culture ( ] i on stimulation with 27 mmol/l glucose (Table 3) . This was followed by a peak in [Ca 2+ ] i , which was followed by irregular oscillations from an elevated plateau. A trace from a registration of a single islet is shown in Fig. 1 , and the means ± SE of seven experiments are shown in Fig. 2A and are quantified in detail in ] i after stimulation with high glucose in 7 of 10 islets from six different donors. A trace from a registration from a single islet is shown in Fig. 1 , and the means ± SE of 10 experiments are shown in Fig. 2A and Table 3 . Furthermore, after a change from (Table 3 ). After culture with 5.5 mmol/l glucose, an offresponse was present in three of seven islets ( ] i response to 27 mmol/l glucose in 27-mmol/l glucose cultured islets to any extent (Fig. 2B, Table 3 ). Culture with diazoxide and 5.5 mmol/l glucose decreased somewhat (by <20%) the glucose-induced measurement in [Ca 2+ ] i (Table 3) .
Arginine-induced [Ca
2+
] i responses are not desensitized by high-glucose culture. Responses to arginine were examined to assess the specificity of the desensitized and abnormal [Ca 2+ ] i responses to glucose. Definite stimulation by 10 mmol/l arginine in the presence of 3.3 mmol/l glucose was recorded in islets cultured with both 5.5 and 27 mmol/l glucose. In contrast to stimulation with glucose, a clear albeit relatively small positive deflection was recorded both after high-and lowglucose culture (Fig. 2C) ] i was somewhat decreased after high-glucose culture (Fig. 2D) .
High-glucose culture diminishes slow [Ca
2+
] i oscillations. The pattern of oscillations during stimulation with 27 mmol/l glucose was markedly different in islets cultured with 27 vs. 5.5 mmol/l glucose. Slow oscillations (0.2-0.5 min -1 ) occurred less frequently in 27-vs. 5.5-mmol/l glucose cultured islets (P < 0.005, Fig. 3A) . Not only the frequency but also the amplitude of slow oscillations (0.2-0.5 min -1 ) was decreased in 27-vs. 5.5-mmol/l glucose cultured islets in terms of total spectral density (P < 0.04, Fig. 3B ). Previous diazoxide normalizes glucose-induced oscillatory activity. Coculture with diazoxide normalized the pattern of oscillations in terms of relative spectral density seen in islets cultured with 27 mmol/l glucose alone. Hence, after coculture with diazoxide and 27 mmol/l glucose, slow oscillations were totally restored (P < 0.005 vs. no previous diazoxide, Fig. 3A ). These effects of diazoxide could not be explained by a drug effect per se because previous diazoxide after culture with low glucose tended to exert the opposite effect (Fig. 3A) .
Previous diazoxide also restored the amplitude of slow oscillations (0.2-0.5 min -1 ) in terms of total spectral density after 27-mmol/l glucose culture (P < 0.02, Fig. 3B ). The 5.5-mmol/l glucose culture with diazoxide did not affect the overall amplitude of slow oscillations (Fig. 3B) . Previous glucose or diazoxide do not affect islet glucose utilization and oxidation. We tested whether the glucose concentration and/or presence of diazoxide during culture would affect glucose metabolism when assessed after culture. However, neither glucose utilization nor oxidation was affected by the culture conditions (Table 4) .
DISCUSSION
The starting point of this study was the demonstration that long-term elevated glucose levels completely and specifically desensitize glucose-induced insulin secretion from human pancreatic islets. The desensitizing effect of long-term elevated glucose levels that we observe is much more pronounced than in rodent islets (13, 15) . Desensitization mimics the severe attenuation of glucose-induced insulin release in type 2 diabetic patients. Although we recognize that all causes of decreased insulin secretion in type 2 diabetes cannot be encompassed by in vitro experiments, our results should still provide insight into mechanisms behind abnormal insulin release in this disease.
The present study demonstrates (for the first time, to our knowledge) that long-term exposure to elevated glucose levels induces profound abnormalities in the regulation of [ that in the present study has not been observed in cultured rodent islets (12) (13) (14) . We note that the attenuated [Ca 2+ ] i response that we observe was also found in islets from a single patient with type 2 diabetes (31) .
Our study also demonstrated that long-term elevated glucose profoundly perturbs glucose-induced oscillatory activity. These effects were obvious despite the nonoptimal glucose concentration used for examining this particular parameter. ] i oscillations and insulin release that has been demonstrated in rodent islets, at least under certain experimental conditions (35, 36) .
Our data with arginine indicate that the abnormalities in glucose-induced regulation of [Ca 2+ ] i are specific for glucose, and the [Ca 2+ ] i increase in response to arginine is unaffected or possibly enhanced by high-glucose culture. These observations are congruent with previous ones in neonatally streptozotocin-induced diabetic rats (10) . Both glucose-and arginine-induced increases in [Ca 2+ ] i result from depolarization of the cell membrane followed by inflow of Ca 2+ through voltage-dependent channels. However, depolarization by glucose is coupled with glucose closure of the ATP-dependent K + channel, an effect that is secondary to an increase in the cytosolic ATP/ADP ratio as a result of glucose metabolism. Depolarization by arginine, on the other hand, is induced by the electrogenic properties of the arginine molecule (37) . These data make the possibility unlikely that a deficiency in [Ca 2+ ] i channel functioning is causing the abnormalities presently seen with glucose as a stimulus.
The effects of arginine were tested with a low concentration of glucose, which in some previous studies had only marginal effects on insulin secretion and on [Ca 2+ ] i . The results obtained after culture with 5.5 mmol/l glucose are consistent with these observations and show no effects on insulin secretion and modest effects on [Ca 2+ ] i . Hyperglycemia is known to left shift the dose response for glucoseinduced insulin secretion as well as to potentiate insulin secretion of other secretagogues (38) . Consistent with this, we observed a stronger insulin response to arginine after culture with 27 mmol/l glucose as well as a tendency for a more marked [Ca 2+ ] i response. Our experiments with diazoxide served to probe the importance of overstimulation for the desensitized insulin response to glucose and the [Ca 2+ ] i abnormalities seen after high-glucose culture. The choice of diazoxide was motivated by its inhibitory effect on glucose-induced insulin secretion, the swift reversibility thereof after 48 h of exposure time in vivo in rats (19) and after 20-22 h of culture of rat pancreatic islets (15) , and the low toxicity in clinical settings (39) .
We found that diazoxide during high-glucose culture preserved an insulin response to glucose during postculture conditions (i.e., when the drug was no longer present). The incremental increase in secretion during a glucose challenge was of the same magnitude as the response of islets cultured with 5.5 mmol/l glucose alone. The beneficial effects of previous diazoxide on glucose-induced insulin secretion could not be explained by an effect of the drug per se. Hence, the presence of diazoxide during culture with normal glucose levels (5.5 mmol/l) had (for unknown reasons) an inhibitory (not a stimulatory) effect on the postculture insulin response to glucose. Altogether, these results strongly indicate an important role for overstimulation behind the desensitized insulin response to glucose.
Our study shows that previous diazoxide had normalizing effects on two important [Ca 2+ ] i abnormalities. First, elevated basal levels of [Ca 2+ ] i after high-glucose culture were decreased by the copresence of diazoxide during culture. Importantly, this effect was glucose dependent because it was not seen after culture with diazoxide with normal glucose levels. Also, a previous study indicated that any effect of diazoxide per se would increase rather than decrease [Ca 2+ ] i (40) . Previous diazoxide reversed a second Ca 2+ abnormality, i.e., oscillatory activity. Thus, the copresence of diazoxide during high-glucose culture normalized the slow (0.2-0.5 min -1 ) [Ca 2+ ] i oscillations during glucose stimulation. Again, this effect appeared not to be an effect of the drug per se because slow oscillations after coculture of diazoxide together with low glucose were not increased, as was the case after coculture with high glucose.
However, previous diazoxide failed to restore to any degree a net [Ca 2+ ] i response to glucose. Notably, this failure was dissociated from a restoring effect on glucose-induced ] i response could be corrected (along with glucose-induced insulin secretion) by including diazoxide during high-glucose culture (8) . Species differences as well as experimental differences (isolated cells in the previous study vs. islets in the present study) could possibly explain these discrepancies.
A further abnormality not corrected by diazoxide was the exaggerated ] i increase to postculture stimulation with glucose seems unlikely. Regarding synchronous oscillations in response to glucose, studies using confocal microscopy in mouse islets indicate that only ␤-cells oscillate (42, 43) . Arginine-induced [Ca 2+ ] i effects could, on the other hand, be influenced by ␣-cell participation because this amino acid is a potent stimulator of glucagon secretion (41) and induces an increase in [Ca 2+ ] i in mouse islets (37, 42) . Note, however, that [Ca 2+ ] i responses to arginine tended to be higher rather than lower after high-glucose culture. Because previous hyperglycemia depresses a glucagon response to arginine (44) ] i was markedly elevated by the high-glucose culture before postculture stimulation with glucose, thus questioning the need for further [Ca 2+ ] i elevation to induce insulin secretion. In this context, note that the fractional release of insulin at low glucose was markedly elevated during basal glucose conditions; this implies a near-maximal effect by [Ca 2+ ] i before the introduction of 27 mmol/l glucose.
The chronic elevation of basal [Ca 2+ ] i may possibly inhibit insulin secretion. Consistent with such a notion, supraphysiological concentrations of extracellular Ca 2+ inhibit secretion (45) . Such inhibition may be linked to or precede [Ca 2+ ] i toxicity, a concept that has been advanced for different cell types (34), including pancreatic ␤-cells (46, 47) .
Along this line of reasoning, the lowering effect of previous diazoxide on basal [Ca 2+ ] i could be important in preserving sensitivity to glucose, especially because this effect was not seen after the presence of diazoxide during normal glucose cultures. However, we note that diazoxide did not reduce elevated basal [Ca 2+ ] i levels to levels seen after culture with 5.5 mmol/l glucose. Furthermore, the reduction in basal [Ca 2+ ] i levels by diazoxide was accompanied by increased rather than decreased release of insulin under basal conditions (although fractional release was decreased vs. culture without diazoxide). One may speculate that a combination of moderately elevated [Ca 2+ ] i along with a glucose-sensitizing effect to [Ca 2+ ] i as part of a K + -ATP channel-independent action of glucose (48, 49) could be responsible for the increased basal secretion.
A role for a decrease in slow [Ca 2+ ] i oscillations for desensitization of glucose-induced insulin secretion is compatible with the importance of such oscillations in the signal-secretion chain of events. The mechanisms responsible for this type of oscillatory activity have yet to be determined. Some oscillatory activity is coupled with glucose metabolism; [Ca 2+ ] i oscillations, for example, have been found to be coupled to oscillations in NADH and ATP/ADP concentrations (50) . In our study, we did not find any gross abnormalities in the glycolytic or oxidative metabolism of glucose either as a result of the glucose concentration during culture or as a result of the presence of diazoxide. (Incidentally, these findings attest to the viability of the islets after high-glucose culture). However, our results do not rule out subtle abnormalities of glucose metabolism that could affect, for example, cytosolic ATP/ADP ratios and that could be important in the present context.
Our findings indicating that overstimulation is responsible for the loss of glucose-induced slow [Ca 2+ ] i oscillations could be clinically important. As mentioned, such oscillations may at least in part underlie pulsatility of insulin secretion. Pulsatile insulin secretion may have better biological effects than continuous insulin release (51), and disturbances in pulsatility of insulin secretion are a characteristic of type 2 diabetic patients (52) and their relatives (53). In obese humans, observations have indicated that increased demands for secretion, such as those that occur during obesity, will diminish orderly pulsatility of insulin, whereas weight loss will restore such pulsatility (54). On these grounds, our results with diazoxide are compatible with the notion that loss of pulsatile insulin secretion in type 2 diabetic patients is related to overstimulation of the patients' ␤-cells.
In conclusion, the present study has demonstrated in human pancreatic islets that a prolonged high-glucose environment in parallel abolishes glucose-induced insulin secretion and glucose-induced [ 
